NKCFO LLC’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

NKCFO LLC’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,500	Closed	-$179K	–	117
2021 Q2	$179K	Buy	+6,500	New	+$128K	0.06%	84

NKCFO LLC's TBIO Position: Q3 2021 in Review

NKCFO LLC sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 6,500 shares — an estimated $179K sold.

NKCFO LLC first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $179K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

NKCFO LLC reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
NKCFO LLC sold 6,500 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $179K.
NKCFO LLC first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
NKCFO LLC's Translate Bio, Inc. Common Stock position peaked at $179K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on NKCFO LLC's 13F filing for Q3 2021, filed 21 Oct 2021.